These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 37770623)

  • 21. PFKFB3 in neovascular eye disease: unraveling mechanisms and exploring therapeutic strategies.
    Liu P; Sun D; Zhang S; Chen S; Wang X; Li H; Wei F
    Cell Biosci; 2024 Feb; 14(1):21. PubMed ID: 38341583
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diurnal variations in angiostatin in human tear fluid: a possible role in prevention of corneal neovascularization.
    Sack RA; Beaton AR; Sathe S
    Curr Eye Res; 1999 Mar; 18(3):186-93. PubMed ID: 10342373
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mediators of ocular angiogenesis.
    Qazi Y; Maddula S; Ambati BK
    J Genet; 2009 Dec; 88(4):495-515. PubMed ID: 20090210
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Scientists take aim at angiogenesis to treat degenerative eye diseases.
    Hampton T
    JAMA; 2004 Mar; 291(11):1309-10. PubMed ID: 15026379
    [No Abstract]   [Full Text] [Related]  

  • 25. Zebrafish (Danio rerio) embryo as a platform for the identification of novel angiogenesis inhibitors of retinal vascular diseases.
    Rezzola S; Paganini G; Semeraro F; Presta M; Tobia C
    Biochim Biophys Acta; 2016 Jul; 1862(7):1291-6. PubMed ID: 27085972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Angiomodulatory properties of Rhodiola spp. and other natural antioxidants.
    Radomska-Leśniewska DM; Skopiński P; Bałan BJ; Białoszewska A; Jóźwiak J; Rokicki D; Skopińska-Różewska E; Borecka A; Hevelke A
    Cent Eur J Immunol; 2015; 40(2):249-62. PubMed ID: 26557041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Inhibition of angiogenesis in the anterior chamber of the eye].
    Bock F; König Y; Dietrich T; Zimmermann P; Baier M; Cursiefen C
    Ophthalmologe; 2007 Apr; 104(4):336-44. PubMed ID: 17372736
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A novel peptide derived from human apolipoprotein E is an inhibitor of tumor growth and ocular angiogenesis.
    Bhattacharjee PS; Huq TS; Mandal TK; Graves RA; Muniruzzaman S; Clement C; McFerrin HE; Hill JM
    PLoS One; 2011 Jan; 6(1):e15905. PubMed ID: 21253017
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gene therapy and control of angiogenesis.
    Francis PJ; Stout JT
    Ophthalmol Clin North Am; 2003 Dec; 16(4):575-82. PubMed ID: 14740998
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Pigment epithelium-derived factor inhibits leptin-induced angiogenesis by suppressing vascular endothelial growth factor gene expression through anti-oxidative properties.
    Yamagishi S; Amano S; Inagaki Y; Okamoto T; Takeuchi M; Inoue H
    Microvasc Res; 2003 May; 65(3):186-90. PubMed ID: 12711260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Ocular neovascularization: a valuable model system.
    Campochiaro PA; Hackett SF
    Oncogene; 2003 Sep; 22(42):6537-48. PubMed ID: 14528278
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Vascular endothelial growth factors and angiogenesis in eye disease.
    Witmer AN; Vrensen GF; Van Noorden CJ; Schlingemann RO
    Prog Retin Eye Res; 2003 Jan; 22(1):1-29. PubMed ID: 12597922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Wnt Signaling in vascular eye diseases.
    Wang Z; Liu CH; Huang S; Chen J
    Prog Retin Eye Res; 2019 May; 70():110-133. PubMed ID: 30513356
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pigment epithelium-derived factor prevents melanoma growth via angiogenesis inhibition.
    Abe R; Fujita Y; Yamagishi S; Shimizu H
    Curr Pharm Des; 2008; 14(36):3802-9. PubMed ID: 19128233
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Inhibition of corneal angiogenesis by local application of vasostatin.
    Wu PC; Yang LC; Kuo HK; Huang CC; Tsai CL; Lin PR; Wu PC; Shin SJ; Tai MH
    Mol Vis; 2005 Jan; 11():28-35. PubMed ID: 15660022
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuropilin regulation of angiogenesis.
    Lampropoulou A; Ruhrberg C
    Biochem Soc Trans; 2014 Dec; 42(6):1623-8. PubMed ID: 25399580
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Future Perspectives of Therapeutic, Diagnostic and Prognostic Aptamers in Eye Pathological Angiogenesis.
    Iturriaga-Goyon E; Buentello-Volante B; Magaña-Guerrero FS; Garfias Y
    Cells; 2021 Jun; 10(6):. PubMed ID: 34200613
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Advanced Technologies of Drug Delivery to the Posterior Eye Segment Targeting Angiogenesis and Ocular Cancer.
    Ansari M; Kulkarni YA; Singh K
    Crit Rev Ther Drug Carrier Syst; 2024; 41(1):85-124. PubMed ID: 37824419
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Intraocular neovascularization.
    Yoshida A; Yoshida S; Ishibashi T; Inomata H
    Histol Histopathol; 1999 Oct; 14(4):1287-94. PubMed ID: 10506944
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Integrins: An Important Link between Angiogenesis, Inflammation and Eye Diseases.
    Mrugacz M; Bryl A; Falkowski M; Zorena K
    Cells; 2021 Jul; 10(7):. PubMed ID: 34359873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.